Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer

Overview of attention for article published in Biomarker Research, April 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 8,627 followers.

A new & important milestone in cancer immunotherapy... quantification of PD-L1 in circulating cancer cells 🧪

RT @cancerscnews: Drs. @JoshLangMD and Ticiana Batista (@LealTiciana) lead @UW_Medicine scientists developed exclusion-based sample prepara…

Drs. @JoshLangMD and Ticiana Batista (@LealTiciana) lead @UW_Medicine scientists developed exclusion-based sample preparation technology to quantify the expression of both PD-L1 and HLA I on #CirculatingTumorCells. 🧫 📑 https://t.co/DSlNcZNotQ https://t.co

RT @NSethakorn: Our paper is out! Detecting tumor heterogeneity in CTCs in NSCLC. Love working with Jen Schehr, @AMTrayn @LealTiciana @Narj…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.